Short Interest in PURE Bioscience (OTCMKTS:PURE) Grows By 100.2%

Posted by Francis Steltz on Aug 16th, 2026

PURE Bioscience (OTCMKTS:PURE – Get Free Report) saw a large increase in short interest in July. As of July 31st, there was short interest totaling 7,738 shares, an increase of 100.2% from the July 15th total of 3,865 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 32,276 shares, the short-interest ratio is presently 0.2 days.

PURE Bioscience Stock Performance

OTCMKTS:PURE opened at $0.08 on Friday. The firm has a market cap of $10.40 million, a P/E ratio of -2.67 and a beta of 0.21. PURE Bioscience has a fifty-two week low of $0.04 and a fifty-two week high of $0.14. The firm has a 50-day simple moving average of $0.07 and a two-hundred day simple moving average of $0.07.

PURE Bioscience (OTCMKTS:PURE – Get Free Report) last posted its quarterly earnings results on Monday, June 15th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.51 million for the quarter.

PURE Bioscience Company Profile

(Get Free Report)

PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.

PURE’s product suite includes concentrate formulations and ready-to-use solutions.

Short Interest in PURE Bioscience (OTCMKTS:PURE) Grows By 100.2%

PURE Bioscience Stock Performance

PURE Bioscience Company Profile

See Also

You might be interested in: